India's Dr Reddy's gets U.S. nod for osteoporosis drug
Home page > News

India's Dr Reddy's gets U.S. nod for osteoporosis drug

www.reuters.com   | 04.05.2012.

(Reuters) - Indian drugmaker Dr Reddy's Laboratories has received U.S. Food and Drug Administration's approval for selling ibandronate sodium tablets used to treat osteoporosis, the regulator's website showed on Thursday.
br />

The tablets are the generic version of Boniva, a brand sold by a unit of Swiss drugmaker Roche.

Cipla, another Indian drugmaker, received U.S. regulatory approval for AIDS treatment drug nevirapine, the website showed. The drug is a generic version of German drugmaker Boehringer Ingelheim's Viramune tablets.

(Reporting by Kaustubh Kulkarni in MUMBAI)


Comments (0) Add Your comment Add news < Previous news Next news >






  Add your news >>>